AstraZeneca among backers as Swiss cancer biotech raises $200 million

59

LONDON (Reuters) – An unlisted Swiss biotech company focused on developing "armed antibodies" to fight cancer has raised $200 million in a funding round backed by AstraZeneca and other private backers.
Source : http://in.reuters.com/